CpG methylation in the Fhit regulatory region: relation to Fhit expression in murine tumors
- 8 March 2004
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 23 (22) , 3990-3998
- https://doi.org/10.1038/sj.onc.1207526
Abstract
To determine if: (1) 5′ CpG island methylation is related to Fhit inactivation; (2) there are tumor or carcinogen-specific methylation patterns, we examined 35 CpG sites in the promoter, exon and intron 1 of the mouse Fhit gene. In primary tumors of lung, urinary bladder and tongue, induced by different carcinogens, 15–35% of sites were methylated, with specific methylation patterns associated with each cancer type, suggesting cancer- or tissue-specific methylation patterns. The methylation patterns were associated with reduced Fhit expression, as determined by immunohistochemical analyses. Methylation of rat Fhit 5′ CpGs in mammary adenocarcinomas, detected by methylation specific PCR amplification, also correlated with reduced gene expression. Thus, there was an overall association between promoter/exon 1 methylation and decreased Fhit expression. In contrast, in cancer-derived cell lines 70–95% of the CpG sites were methylated. This is the first detailed study of the relationship between Fhit 5′ CpG island methylation and Fhit expression in murine tumors, our main models for preclinical cancer studies, and provides evidence that loss of Fhit expression and methylation are correlated in these mouse models and these models will be useful to examine the complex relationships among gene expression, methylation patterns and organ specificity.Keywords
This publication has 16 references indexed in Scilit:
- DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated RasOncogene, 2003
- Quantitative PCR identifies a minimal deleted region of 120 kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcomeLeukemia, 2003
- DNA methylation and gene silencing in cancer: which is the guilty party?Oncogene, 2002
- FRA3B and other common fragile sites: the weakest linksNature Reviews Cancer, 2001
- Detection of 1p and 19q Loss in Oligodendroglioma by Quantitative Microsatellite Analysis, a Real-Time Quantitative Polymerase Chain Reaction AssayThe American Journal of Pathology, 2001
- Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumoursOncogene, 2001
- Loss of FHIT Expression in Transitional Cell Carcinoma of the Urinary BladderThe American Journal of Pathology, 2000
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences, 1996
- The FHIT Gene at 3p14.2 Is Abnormal in Lung CancerCell, 1996
- Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.Proceedings of the National Academy of Sciences, 1994